An indirect, solid phase, microplate enzyme-linked immunosorbent assay (ELISA) was found to be highly sensitive and reliable for detecting antibodies to the group B Coxsackieviruses and other picornaviruses. Conditions for obtaining maximum sensitivity and reproducibility of the indirect ELISA are described. Antibody titres were comparable to those obtained by the virus neutralization test and over 50 times higher than those obtained by the complement-fixation test. Purified virions used in the indirect ELISA reacted with low levels of cross-reacting heterotypic antibodies elicited by each of the six group B Coxsackieviruses, although homotypic reactions resulted in highest titres.
CrowellR. L.,
SyvertonJ. T.1961; The mammalian cell virus relationship. VI. Sustained infection of HeLa cells by Coxsackie B3 virus and effect on superinfection. Journal of Experimental Medicine 113:419–435
EngvallE.,
PerlmannP.1972; Enzyme-linked immunosorbent assay, ELISA. III. Quantitation of specific antibodies by enzyme-labelled anti-immunoglobulin in antigen-coated tubes. Journal of Immunology 109:129–135
GilmanS. C.,
DochertyJ. J.1977; Detection of antibodies specific for herpes simplex virus in human sera by the enzyme-linked immunsorbent assay. Journal of Infectious Diseases, Supplement 136:S286–S293
KraftL. M.,
MelnickJ. L.1950; Immunological reactions of the Coxsackieviruses. II. The complement fixation test. Journal of Experimental Medicine 92:483–497
LennetteE. H.,
MelnickJ. L.,
MagoffinR. L.1974; Clinical virology: introduction to method. In Manual of Clinical Microbiology pp 667–677 Edited by
LennetteE. H.,
SpauldingE. H.,
TruantJ. P.
Washington, D,. C.: American Society of Microbiology;
LowryO. H.,
RosebroughN. J.,
FarrA. L.,
RandallR. J.1951; Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193:265–275
MacwilliamK. M.,
CooperM. A.1974; Antibody levels in human sera measured by the fluorescent-antibody technique against the Coxsackie B viruses types 1 to 5 grown in Hep 2 cells compared with results obtained by neutralization. Journal of Clinical Pathology 27:825–827
MelnickJ. L.,
LedinkoN.1950; Immunological reactions of the Coxsackievirus. I. The neutralization test: techniques and applications. Journal of Experimental Medicine 92:463–482
SchmidtN. J.,
DennisJ.,
FrommhagenL. H.,
LennetteE. H.1963; Serologic reactivity of certain antigens obtained by fractionation of Coxsackie viruses in cesium chloride density gradients. Journal of Immunology 90:654–662
SchmidtN. J.,
LennetteE. H.1962; Gel double diffusion studies with group B and group A, type 9 coxsackie viruses. I. The technique and reactions obtained with hyperimmune animal sera and human sera. Journal of Immunology 89:85–95
SvehagS. E.,
MandelB.1964; The formation and properties of poliovirus-neutralizing antibody. I. 19S and 7S antibody formation: difference in kinetics and antigen dose requirements for induction. Journal of Experimental Medicine 119:1–19
VollerA.,
BidwellD. E.1976; Enzyme-immunoassays for antibodies in measles, cytomegalovirus infection and after rubella vaccination. British Journal of Experimental Pathology 57:243–247
VollerA.,
BidwellD.,
HuldtG.,
EngvallE.1974; A microplate method of enzyme-linked immunosorbent assay and its application to malaria. Bulletin of the World Health Organization 51:209–211